Skip to main content
. 2021 May 17;24(5):551–557. doi: 10.1089/jmf.2020.0097

FIG. 1.

FIG. 1.

Study design flow diagram of Macumax® supplementation in patients with dry AMD. Of the 40 subjects who completed the study, 22 were screened at Site 1 and 18 were screened at Site 2. No one dropped out. All 40 subjects were included for the safety and efficacy analyses. AMD, age-related macular degeneration.